Ülke: Yeni Zelanda
Dil: İngilizce
Kaynak: Ministry for Primary Industries
infectious bovine rhinotrocheitis virus (inactivated); pasteurella haemolytica (inactivated); pasteurella haemolytica (inactivated)
Schering-Plough Animal Health Limited
infectious bovine rhinotrocheitis virus (inactivated) 0 vaccine; pasteurella haemolytica (inactivated) 0 vaccine; pasteurella haemolytica (inactivated) 0 vaccine
Vaccine
2018-10-12
BOVILIS MH+IBR 100 mL and 250 mL – Leaflet, Carton and Label A011518 Page 1 of 7 BOVILIS MH+IBR 06-Oct-22 Leaflet RESTRICTED VETERINARY MEDICINE KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY BOVILIS ® MH+IBR INACTIVATED VACCINE FOR THE ACTIVE IMMUNISATION OF CATTLE AGAINST BOVINE RESPIRATORY DISEASE (BRD) CAUSED BY _MANNHEIMIA HAEMOLYTICA_ AND INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS (BOVINE HERPES VIRUS TYPE 1) AND TO AID IN THE CONTROL OF BRD BY REDUCING THE INTENSITY AND DURATION OF THE CLINICAL SIGNS OF INFECTION AND REDUCING EXCRETION OF THE FIELD VIRUS. READ ENTIRE LEAFLET BEFORE USE. DOSAGE AND ADMINISTRATION Dose = 2 mL by subcutaneous injection into the anterior third of the neck. Shake well to mix before use. Ensure vaccinator gun delivers correct dose. Use sterile equipment and change needles frequently. Vaccinate only healthy, clean and dry animals. Bovilis MH+IBR vaccine is safe for use in pregnant cows and heifers. RECOMMENDED VACCINATION PROGRAMME PRIMARY VACCINATION The primary course consists of a sensitiser dose (2 mL) followed by a booster dose (2 mL). For flexibility, the booster dose can be given between 2 weeks to 9 months following the initial vaccination. Vaccination should be undertaken in advance of situations with a high potential for BRD to occur as onset of active immunity starts 14 days after the second dose. These situations may involve assembly, mixing or movement of cattle e.g. artificially reared dairy calves, cattle moving between herds or regions and cattle destined for feedlots. If cattle are destined for live export, the pre- export testing protocols of the destination market should be considered. ADVERSE REACTIONS A slight transient swelling may be observed at the site of vaccination, which typically resolves within 21 days. Occasionally, transient pyrexia may also occur. ADDITIONAL INFORMATION Field data has demonstrated that the second dose of Bovilis MH+IBR vaccine can be administered from between 2 weeks to 9 months following the initial vaccination. Bovine R Belgenin tamamını okuyun